• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名急性髓系白血病患者在接受泊沙康唑治疗期间发生了浅白隐球菌突破性感染。

Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.

作者信息

Rieger C, Geiger S, Herold T, Nickenig C, Ostermann H

机构信息

Department of Hematology/Oncology, University Hospital Grosshadern, Ludwig Maximilian University, Marchioninistrasse 15, 81377, Munich, Germany.

出版信息

Eur J Clin Microbiol Infect Dis. 2007 Nov;26(11):843-5. doi: 10.1007/s10096-007-0366-5.

DOI:10.1007/s10096-007-0366-5
PMID:17690928
Abstract

A neutropenic patient with acute myeloid leukaemia experienced a breakthrough infection of Trichosporon asahii during posaconazole treatment. After treatment was changed to a combination therapy with voriconazole and liposomal amphotericin B, the infection resolved. Posaconazole works effectively as an antifungal prophylaxis and salvage therapy in rare invasive fungal infections. This case however illustrates that breakthrough infections with T. asahii may occur during posaconazole treatment.

摘要

一名急性髓系白血病的中性粒细胞减少患者在接受泊沙康唑治疗期间发生了阿萨希毛孢子菌突破性感染。治疗改为伏立康唑和脂质体两性霉素B联合治疗后,感染得到缓解。泊沙康唑在罕见的侵袭性真菌感染中作为抗真菌预防和挽救治疗有效。然而,该病例表明在泊沙康唑治疗期间可能发生阿萨希毛孢子菌突破性感染。

相似文献

1
Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.一名急性髓系白血病患者在接受泊沙康唑治疗期间发生了浅白隐球菌突破性感染。
Eur J Clin Microbiol Infect Dis. 2007 Nov;26(11):843-5. doi: 10.1007/s10096-007-0366-5.
2
Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.一名中性粒细胞减少的儿童因阿萨希毛孢子菌引起的真菌血症,对两性霉素B耐药:伏立康唑清除真菌。
J Pediatr Hematol Oncol. 2005 May;27(5):283-5. doi: 10.1097/01.mph.0000164865.70522.d7.
3
Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.伏立康唑成功治疗急性髓系白血病患者的突破性阿萨希毛孢子菌血症
Clin Infect Dis. 2006 Aug 15;43(4):e39-41. doi: 10.1086/505970. Epub 2006 Jun 26.
4
Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.伏立康唑成功治疗1例急性髓系白血病患者播散性阿萨希毛孢子菌感染
Eur J Clin Microbiol Infect Dis. 2002 Dec;21(12):892-6. doi: 10.1007/s10096-002-0841-y. Epub 2002 Nov 1.
5
Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.伏立康唑治疗下急性髓系白血病患者中由近平滑念珠菌引起的致命性播散性感染:对曲霉菌属突破性感染的综述
Mycopathologia. 2020 Apr;185(2):377-388. doi: 10.1007/s11046-019-00416-w. Epub 2019 Dec 18.
6
Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B.伏立康唑联合脂质体两性霉素B成功治疗1例难治性急性髓系白血病合并毛孢子菌血症患者
Transpl Infect Dis. 2012 Apr;14(2):184-7. doi: 10.1111/j.1399-3062.2011.00670.x. Epub 2011 Sep 28.
7
Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.伏立康唑在豚鼠侵袭性毛孢子菌病模型中的疗效。
Antimicrob Agents Chemother. 2006 Jun;50(6):2240-3. doi: 10.1128/AAC.00045-06.
8
Voriconazole for both successful treatment of disseminated Trichosporon asahii infection and subsequent cord blood transplantation in an infant with acute myelogenous leukemia.伏立康唑成功治疗了一名急性髓性白血病婴儿的播散性阿萨希毛孢子菌感染,并随后进行了脐血移植。
Bone Marrow Transplant. 2011 Feb;46(2):310-1. doi: 10.1038/bmt.2010.96. Epub 2010 May 3.
9
Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.一名急性白血病中性粒细胞减少患者在接受卡泊芬净治疗时发生突破性阿萨希毛孢子菌血症。
Infection. 2008 Feb;36(1):68-70. doi: 10.1007/s15010-007-6278-6. Epub 2007 Sep 19.
10
Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.来自一家巴西医院的毛孢子菌分离株的分子鉴定及药敏试验
Rev Iberoam Micol. 2008 Dec 31;25(4):221-5.

引用本文的文献

1
Detection of invasive in patient blood by a fungal PCR array.通过真菌PCR芯片检测患者血液中的侵袭性真菌。
Access Microbiol. 2021 Dec 3;3(12):000285. doi: 10.1099/acmi.0.000285. eCollection 2021.
2
Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.伏立康唑治疗下急性髓系白血病患者中由近平滑念珠菌引起的致命性播散性感染:对曲霉菌属突破性感染的综述
Mycopathologia. 2020 Apr;185(2):377-388. doi: 10.1007/s11046-019-00416-w. Epub 2019 Dec 18.
3
Catheter-Related Trichosporon asahii Bloodstream Infection in a Neutropenic Patient with Myelodysplastic Syndrome.

本文引用的文献

1
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.泊沙康唑与氟康唑或伊曲康唑对中性粒细胞减少患者的预防作用比较
N Engl J Med. 2007 Jan 25;356(4):348-59. doi: 10.1056/NEJMoa061094.
2
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.泊沙康唑或氟康唑用于严重移植物抗宿主病的预防。
N Engl J Med. 2007 Jan 25;356(4):335-47. doi: 10.1056/NEJMoa061098.
3
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.
一名患有骨髓增生异常综合征的中性粒细胞减少患者发生的导管相关阿萨希毛孢子菌血流感染
Infect Chemother. 2018 Jun;50(2):138-143. doi: 10.3947/ic.2018.50.2.138.
4
Successful treatment of breakthrough disseminated fungemia in a patient with acute myeloid leukemia receiving itraconazole prophylaxis.在接受伊曲康唑预防治疗的急性髓性白血病患者中成功治疗突破性播散性真菌血症。
Med Mycol Case Rep. 2017 Nov 28;20:1-3. doi: 10.1016/j.mmcr.2017.11.006. eCollection 2018 Jun.
5
Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis.囊性纤维化中真菌感染的定义、预防和治疗的进展。
Mycopathologia. 2018 Feb;183(1):21-32. doi: 10.1007/s11046-017-0182-0. Epub 2017 Jul 31.
6
In Vitro Activity of Berberine Alone and in Combination with Antifungal Drugs Against Planktonic Forms and Biofilms of Trichosporon Asahii.单独使用小檗碱和联合使用抗真菌药物对阿萨希丝孢酵母浮游形式和生物膜的体外活性。
Mycopathologia. 2017 Oct;182(9-10):829-837. doi: 10.1007/s11046-017-0119-7. Epub 2017 Jan 31.
7
Invasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen.侵袭性毛孢子菌感染:对一种再度出现的真菌病原体的系统评价
Front Microbiol. 2016 Oct 17;7:1629. doi: 10.3389/fmicb.2016.01629. eCollection 2016.
8
Genetic diversity and antifungal susceptibility testing of Trichosporon asahii isolated of Intensive Care Units patients.从重症监护病房患者中分离的近平滑假丝酵母的遗传多样性和抗真菌药敏试验。
Braz J Microbiol. 2008 Jul;39(3):585-92. doi: 10.1590/S1517-838220080003000033. Epub 2008 Sep 1.
9
Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov.卡塔尔临床标本中分离出的毛孢子菌属菌种的分子鉴定及药敏性:多哈毛孢子菌(Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov.)的分离
J Clin Microbiol. 2009 Jun;47(6):1791-9. doi: 10.1128/JCM.02222-08. Epub 2009 Mar 25.
泊沙康唑治疗对传统疗法难治或不耐受的侵袭性曲霉病患者:一项外部对照试验。
Clin Infect Dis. 2007 Jan 1;44(1):2-12. doi: 10.1086/508774. Epub 2006 Nov 28.
4
Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance.新兴真菌病原体阿萨希毛孢子菌的生物膜形成:发育、结构及抗真菌耐药性
Antimicrob Agents Chemother. 2006 Oct;50(10):3269-76. doi: 10.1128/AAC.00556-06.
5
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.治疗真菌感染的新型药物:临床疗效与覆盖范围的差距
Clin Infect Dis. 2006 Oct 15;43(8):1060-8. doi: 10.1086/507891. Epub 2006 Sep 8.
6
Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome.三级护理癌症中心的毛孢子菌病:危险因素、变化的谱型及预后的决定因素
Scand J Infect Dis. 2004;36(8):564-9. doi: 10.1080/00365540410017563.
7
Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.伏立康唑成功治疗1例急性髓系白血病患者播散性阿萨希毛孢子菌感染
Eur J Clin Microbiol Infect Dis. 2002 Dec;21(12):892-6. doi: 10.1007/s10096-002-0841-y. Epub 2002 Nov 1.
8
In vitro antifungal susceptibilities of Trichosporon species.丝孢酵母属菌种的体外抗真菌药敏性
Antimicrob Agents Chemother. 2002 Apr;46(4):1144-6. doi: 10.1128/AAC.46.4.1144-1146.2002.
9
Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol.癌症患者血源性毛孢子菌病:12例报告,其中5例为接受伊曲康唑预防治疗期间发病。
Support Care Cancer. 1999 Jan;7(1):39-43. doi: 10.1007/s005200050221.
10
Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review.唑类药物治疗毛孢子菌病:8例患者的临床评估、小鼠感染的实验性治疗及综述
Clin Infect Dis. 1992 Nov;15(5):781-7. doi: 10.1093/clind/15.5.781.